ATAI Life Sciences NV (9VC) — Tangible Net Worth Ratio
ATAI Life Sciences NV (9VC) has a Tangible Net Worth Ratio of 91.0% as of September 2025. This metric is calculated by deducting intangible assets (€14.41 Million) from net assets (€159.91 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 9VC current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
ATAI Life Sciences NV Tangible Net Worth Ratio (2019–2024)
This chart shows how ATAI Life Sciences NV's Tangible Net Worth Ratio has changed across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 91.0%, reflecting net assets of €159.91 Million with intangible assets of €14.41 Million EUR. See operational self-sufficiency of ATAI Life Sciences NV to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for ATAI Life Sciences NV (2019–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for ATAI Life Sciences NV from 2019 to 2024, covering 6 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 9VC stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.2% | €116.55 Million | €3.25 Million | €159.39 Million | ▼ -2.1 pp |
| 2023 | 99.3% | €244.32 Million | €1.77 Million | €293.48 Million | ▼ -0.7 pp |
| 2022 | 100.0% | €265.77 Million | €0.00 | €305.44 Million | ▲ +0.0 pp |
| 2021 | 100.0% | €385.96 Million | €0.00 | €414.17 Million | ▲ +0.0 pp |
| 2020 | 100.0% | €95.37 Million | €0.00 | €111.55 Million | ▲ +0.0 pp |
| 2019 | 100.0% | €59.64 Million | €0.00 | €62.12 Million | — |